Disease/Infection News

RSS

Majority of Europeans not concerned about H1N1

Three quarters of European people surveyed between the 30th April and 6th May 2009 said they were either not at all concerned or only a little concerned about swine flu.

6 Oct 2009

HIV prevalence among African Americans is ten times greater than the prevalence among whites

HIV prevalence among African Americans is ten times greater than the prevalence among whites. This racial disparity in HIV prevalence has persisted in the face of both governmental and private actions, involving many billions of dollars, to combat HIV.

6 Oct 2009

New York health workers protest H1N1 vaccine mandate

The first doses of H1N1 vaccines are expected to be released this week and a controversy brews as health workers protest a flu vaccine mandate. CBS News reports that health care workers in New York's capital "vowed to fight an unprecedented order from state health officials: a requirement for every health care worker to get seasonal and H1N1 flu shots or face the possibility of being fired."

6 Oct 2009

U.N. officials highlight need for vaccine assistance to poor countries

U.N. officials on Sunday said that the H1N1 (swine flu) virus had arrived in poorer countries, highlighting a growing need for financial assistance and H1N1 vaccines for such regions, SAPA/News24.com reports.

6 Oct 2009

Research reveals that 52% Americans are not worried about H1N1 virus and its impact

As the first recipients of the H1N1 vaccine are vaccinated, more than half of Americans surveyed (52 percent) do not believe the H1N1 virus, or Swine Flu, will have a major impact in the United States compared to 44 percent who believe it will, according to the results of a new Deloitte Center for Health Solutions survey.

6 Oct 2009

BBC examines 'huge imbalance' between funding for HIV/AIDS, other health needs in Uganda

The BBC examines the balance between funding for HIV/AIDS and for the broader health system and other diseases in Uganda.

6 Oct 2009

News outlets examines health impact of disasters in Indonesia, Samoa, Philippines

In Indonesia, "[r]escue workers called off the search Monday for life under the rubble left by a massive earthquake, focusing instead on bringing aid to survivors," the Agence France-Presse reports. "The United Nations has said at least 1,100 people were killed in the disaster, but estimates of the final toll range up to 5,000. The official toll stood at 650 dead and 672 missing, according to the health ministry," the news service writes (Belford, 10/5).

6 Oct 2009

MSF calls on drug companies to pool HIV patents

Medecins Sans Frontieres (MSF) recently launched an e-mail campaign calling on nine of the world's largest pharmaceutical companies to "release their patents on specific HIV drugs into a collective pool that will increase access and affordability to treatment in developing countries," Inter Press Service reports (Borde, 10/1).

5 Oct 2009

Also in Global Health news: World Bank budget concerns; Ethiopia prepares for malaria surge; malnutrition in Yemen; malaria prevention in Africa

Before the start of the annual meetings of the World Bank and International Monetary Fund World Bank on Friday, World Bank President Robert Zoellick warned that the international lender expects to "face serious constraints" by the middle of next year unless developed nations provide the bank with more resources, the Associated Press reports.

5 Oct 2009

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.

5 Oct 2009

Majority of Americans believe they are well-protected from H1N1

A new Harris poll, commissioned by SCA Tissue North America’s Tork® brand, reveals that 74 percent of U.S. adults say it is unlikely they will contract H1N1 this year.

5 Oct 2009

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

Theraclone Sciences, Inc., a Seattle-based biotechnology company, and Zenyaku Kogyo Co., Ltd., a pharmaceutical company based in Tokyo, today announced that they have entered into a multi-year research and development agreement.

5 Oct 2009

NOAA awards $457,000 grant to track and manage outbreaks of toxic red tide algae

NOAA has awarded $457,000 in competitive grant funding to support three projects to better track and manage outbreaks of toxic red tide algae that threaten public health and New England's shellfish industry. The grant covers the first year of what will be multi-year projects. Anticipated to cost almost $1.5 million over the next three years, they will be carried out by the Woods Hole Oceanographic Institution, the University of Maine and the University of Texas.

5 Oct 2009

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus (SynConTM) H1N1 influenza vaccine candidates achieved protective antibody responses against the novel pandemic influenza A/H1N1 (2009) in 100% of tested ferrets.

5 Oct 2009

American Lung Association kicks off its Faces of Influenza campaign in Miami

The American Lung Association of Florida-South Area is kicking off its 2009-2010 Faces of Influenza initiative by conducting a public influenza panel discussion to help Miami area residents understand the seriousness of seasonal influenza and the importance of annual vaccination. The meeting will address the latest flu statistics and benefits of vaccination, especially among high-risk groups.

3 Oct 2009

The EURORDIS and NORD rare disease organizations form a partnership

The leading advocacy groups for Americans and Europeans with rare diseases -- the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) -- have signed a Memorandum of Understanding to join forces on several key strategic initiatives on behalf of rare disease patients and their families.

3 Oct 2009

HSPH's survey on H1N1 vaccines

In a new survey, Harvard School of Public Health (HSPH) researchers found that just 40% of adults are "absolutely certain" they will get the H1N1 vaccine for themselves, and 51% of parents are "absolutely certain" that they will get the vaccine for their children. The survey examined the reasoning among those who said they would not get the vaccine or might not. This is the latest in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program at HSPH. The polling was done September 14-20, 2009.

3 Oct 2009

Publix Pharmacies offers to compound Tamiflu into an oral suspension for no additional charge

In response to the shortage of Tamiflu in liquid form, all 795 Publix Pharmacies will offer to compound Tamiflu into an oral suspension.

3 Oct 2009

Misuse of aspirin might have caused high death rate during 1918-1919 influenza pandemic

The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high.

3 Oct 2009

FHC launches its second-generation female condom in the U.S.

The Female Health Company announced today that its second-generation FC2 Female Condom®, which received regulatory approval from the Food and Drug Administration in March as an HIV prevention method, is now available for purchase in the United States.

3 Oct 2009

Disease/Infection News

Majority of Europeans not concerned about H1N1

HIV prevalence among African Americans is ten times greater than the prevalence among whites

New York health workers protest H1N1 vaccine mandate

U.N. officials highlight need for vaccine assistance to poor countries

Research reveals that 52% Americans are not worried about H1N1 virus and its impact

BBC examines 'huge imbalance' between funding for HIV/AIDS, other health needs in Uganda

News outlets examines health impact of disasters in Indonesia, Samoa, Philippines

MSF calls on drug companies to pool HIV patents

Also in Global Health news: World Bank budget concerns; Ethiopia prepares for malaria surge; malnutrition in Yemen; malaria prevention in Africa

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

Majority of Americans believe they are well-protected from H1N1

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

NOAA awards $457,000 grant to track and manage outbreaks of toxic red tide algae

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

American Lung Association kicks off its Faces of Influenza campaign in Miami

The EURORDIS and NORD rare disease organizations form a partnership

HSPH's survey on H1N1 vaccines

Publix Pharmacies offers to compound Tamiflu into an oral suspension for no additional charge

Misuse of aspirin might have caused high death rate during 1918-1919 influenza pandemic

FHC launches its second-generation female condom in the U.S.

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News